Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer

Lung Cancer

Volumn 83, Issue 1, 2014, Pages 97-101

  Inagaki, Noriko ^a   Kibata, Kayoko ^a   Tamaki, Takeshi ^a   Shimizu, Toshiki ^a   Nomura, Shosaku ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Mean platelet volume; Non small cell lung cancer; Overall survival time; Platelet count; Predictive factor; Retrospective study

Indexed keywords

C REACTIVE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL COUNTER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; VERY ELDERLY;

MEAN PLATELET VOLUME; NON-SMALL CELL LUNG CANCER; OVERALL SURVIVAL TIME; PLATELET COUNT; PREDICTIVE FACTOR; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84891738545     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.08.020     Document Type: Article

References (29)

1. Thompson C.B., Jakubowski J.A. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988, 72(1):1-8.
2. Thompson C.B., Jakubowski J.A., Quinn P.G., Deykin D., Valeri C.R. Platelet size and age determine platelet function independently. Blood 1984, 63(6):1372-1375.
3. Azab B., Torbey E., Singh J., Akerman M., Khoueiry G., McGinn J.T., Widmann W.D., Lafferty J. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011, 22(8):557-566.
4. Slavka G., Perkmann T., Haslacher H., Greisenegger S., Marsik C., Wagner O.F., Endler G. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011, 31(5):1215-1218.
5. Kurt M., Onal I.K., Sayilir A.Y., Beyazit Y., Oztas E., Kekilli M., Turhan N., Karaman K., Akdogan M. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 2012, 59(117):1580-1582.
6. Cho S.Y., Yang J.J., You E., Kim B.H., Shim J., Lee H.J., Lee W.I., Suh J.T., Park T.S. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2012, 28. 10.3109/09537104.2012.701028.
7. Osada J., Rusak M., Kamocki Z., Dabrowska M.I., Kedra B. Platelet activation in patients with advanced gastric cancer. Neoplasma 2010, 57(2):145-150.
8. Matowicka-Karna J., Kamocki Z., Polińska B., Osada J., Kemona H. Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol 2013, 2013. Article ID 401623, 6 pages. http://dx.doi.org/10.1155/2013/401623.
9. Aoe K., Hiraki A., Ueoka H., Kiura K., Tabata M., Tanaka M., Tanimoto M. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 2004, 71(2):170-173.
10. Tomita M., Shimizu T., Hara M., Ayabe T., Onitsuka T. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2008, 7(4):613-615.
11. Gonzalez Barcala F.J., Garcia Prim J.M., Moldes Rodriguez M., Alvarez Fernandez J., Rey M.J., Pose Reino A., Valdes Cuadrado L. Platelet count: association with prognosis in lung cancer. Med Oncol 2010, 27(2):357-362.
12. Goldstraw P., Crowley J., Chansky K., et al. International Association for the Study of Lung Cancer International Staging Committee. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 28:706-714.
13. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136(1):260-271.
14. Chu S.G., Becker R.C., Berger P.B., Bhatt D.L., Eikelboom J.W., Konkle B., Mohler E.R., Reilly M.P., Berger J.S. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010, 8(1):148-156.
15. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular eventsα. Stroke 2004, 35(7):1688-1691.
16. Khode V., Sindhur J., Kanbur D., Ruikar K., Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: a case control study. J Cardiovasc Dis Res 2012, 3:272-275.
17. Mutlu H., Artis T.A., Erden A., Akca Z. Alteration in Mean Platelet Volume and Platicrit Values in Patients With Cancer That Developed Thrombosis. Clin Appl Thromb Hemost 2013, 19(3):331-333. 10.1177/1076029611433644.
18. Aksoy S., Kilickap S., Hayran M., Harputluoglu H., Koca E., Dede D.S., Erman M., Turker A. Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. Int J Lab Hematol 2008, 30:214-219.
19. Karagö B., Alacacioǧlu A., Bilgi O., et al. Platelet count and platelet distribution width increase in lung cancer patients. Anatol J Clin Investig 2009, 3:32-34.
20. Levin J., Bessman J.D. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med 1983, 101(2):295-307.
21. Scagliotti G., Gatti E., Ferrari G., Mutti L., Pozzi E. Tnp-alpha determination in serum and pleural effusion in patients with lung-cancer. Int J Oncol 1995, 6:147-151.
22. Kaminska J., Kowalska M., Kotowicz B., Fuksiewicz M., Glogowski M., Wojcik E., Chechlinska M., Steffen J. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor. Oncology 2006, 70:115-125.
23. Kayacan O., Karnak D., Beder S., Güllü E., Tutkak H., Senler F.C., Köksal D. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol 2006, 29:328-335.
24. Gasparyan A.Y., Ayvazyan L., Mikhailidis D.P., Kitas G.D. Mean platelet volume: a link between thrombosis and inflammationα. Curr Pharm Des 2011, 17:47-58.
25. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005, 115:3339-3347.
26. Thomas G.M., Panicot-Dubois L., Lacroix R., Dignat-George F., Lombardo D., Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 2009, 206:1913-1927.
27. Numico G., Garrone O., Dongiovanni V., Silvestris N., Colantonio I., Di Costanzo G., Granetto C., Occelli M., Fea E., Heouaine A., Gasco M., Merlano M. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 2005, 103:994-999.
28. Tesselaar M.E., Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007, 13:362-367.
29. Malgor R.D., Bilfinger T.V., Labropoulos N. A systematic review of pulmonary embolism in patients with lung cancer. Ann Thorac Surg 2012, 94:311-316.